GPX4 and gastrointestinal stromal tumor: A recent study from Ishida et al. [26] demonstrated that the GPX4 inhibitor RSL3 induced ferroptotic cell death in imatinib-sensitive GIST-T1 cells and imatinib-resistant GIST-R8.